# Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research. Phase 3b

> **NCT07713784** · NA · NOT_YET_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 1000 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BEHAVIORAL:** Epigenetics Video
- **BEHAVIORAL:** Individual Responsbility Video
- **BEHAVIORAL:** External Responsibility Video

## Key facts

- **NCT ID:** NCT07713784
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07713784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07713784, "Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research. Phase 3b". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07713784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*